Use of Fractional Factorial Designs in Antiviral Drug Studies
- 8 February 2012
- journal article
- research article
- Published by Wiley in Quality and Reliability Engineering International
- Vol. 29 (2) , 299-304
Abstract
Experimental design and analysis is an effective and commonly used tool in scientific investigations and industrial applications. Many successful applications have been reported in engineering domains, such as chemical engineering, electrical engineering, and mechanical engineering. However, few cases have been reported in biological research, particularly in virology study. Antiviral drug combinations are increasingly used to reduce possible drug‐resistant viral mutant and reduce cytotoxicity. Drug combinations have often been reported to have higher efficacy and lower individual drug dosage. However, the combined antiviral drug effect is generally hard to assess. One important reason is due to the complex interactions between biological systems and drug molecules. We report a study using fractional factorial designs to investigate a biological system with Herpes simplex virus type 1 and five antiviral drugs. The experiment uses a novel composite design that consists of a 16‐run fractional factorial design and an 18‐run orthogonal array. The results indicate that two chemical drugs, Ribavirin and Acyclovir, are more effective than three Interferon drugs. Furthermore, significant interactions exist within the Interferon drug group and within the Ribavirin‐Acyclovir chemical drug group, but the interactions between the Interferon group and the chemical group are not significant. These observations have major implications in the understanding of antiviral drug mechanism towards better design of combinatorial antiviral drug therapy. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 21 references indexed in Scilit:
- Drug Resistance Mutations in HSV-1 UL5 Selected using a Helicase–Primase Inhibitor: Frequency and Effects on Virus Growth and PathogenicityAntiviral Research, 2009
- Recent developments in nonregular fractional factorial designsStatistics Surveys, 2009
- Antiviral drugs in current clinical useJournal of Clinical Virology, 2004
- Multiple mechanisms for HSV-1 induction of interferon α production by peripheral blood mononuclear cellsArchives of Virology, 2003
- Ribavirin inhibits DNA, RNA, and protein synthesis in PHA‐stimulated human peripheral blood mononuclear cells: Possible explanation for therapeutic efficacy in patients with chronic HCV infectionJournal of Medical Virology, 2002
- Alpha/Beta Interferon and Gamma Interferon Synergize To Inhibit the Replication of Herpes Simplex Virus Type 1Journal of Virology, 2002
- Seroprevalence of HSV-1 and HSV-2 infection in the general French populationSexually Transmitted Infections, 2002
- A Class of Three-Level Experimental Designs for Response Surface ModelingTechnometrics, 2000
- Herpes Simplex Virus Infections of the Central Nervous System: Therapeutic and Diagnostic ConsiderationsClinical Infectious Diseases, 1995
- A protein tyrosine kinase in the interferon αβ signaling pathwayCell, 1992